Voyager Therapeutics Inc (VYGR)
6.81
-0.20
(-2.85%)
USD |
NASDAQ |
Nov 12, 14:57
Voyager Therapeutics Revenue (TTM): 143.77M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 143.77M |
March 31, 2024 | 119.04M |
December 31, 2023 | 250.01M |
September 30, 2023 | 158.40M |
June 30, 2023 | 194.87M |
March 31, 2023 | 190.73M |
December 31, 2022 | 40.91M |
September 30, 2022 | 70.53M |
June 30, 2022 | 30.92M |
March 31, 2022 | 31.57M |
December 31, 2021 | 37.41M |
September 30, 2021 | 15.88M |
June 30, 2021 | 132.24M |
March 31, 2021 | 159.56M |
December 31, 2020 | 171.13M |
September 30, 2020 | 197.26M |
June 30, 2020 | 99.86M |
March 31, 2020 | 117.26M |
Date | Value |
---|---|
December 31, 2019 | 104.39M |
September 30, 2019 | 73.72M |
June 30, 2019 | 55.39M |
March 31, 2019 | 11.87M |
December 31, 2018 | 7.619M |
September 30, 2018 | 11.96M |
June 30, 2018 | 11.01M |
March 31, 2018 | 9.612M |
December 31, 2017 | 10.13M |
September 30, 2017 | 6.151M |
June 30, 2017 | 8.311M |
March 31, 2017 | 10.85M |
December 31, 2016 | 14.22M |
September 30, 2016 | 16.80M |
June 30, 2016 | 18.42M |
March 31, 2016 | 19.59M |
December 31, 2015 | 17.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
15.88M
Minimum
Sep 2021
250.01M
Maximum
Dec 2023
119.25M
Average
119.04M
Median
Mar 2024
Revenue (TTM) Benchmarks
Rhythm Pharmaceuticals Inc | 112.53M |
NovaBay Pharmaceuticals Inc | 12.02M |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |